Target validation: the Parkinson disease perspective.
Standaert
David G
DG
Yacoubian
Talene A
TA
D000818:Animals; D017173:Caenorhabditis elegans / Q000378:metabolism; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D006801:Humans; D010300:Parkinson Disease / Q000235:genetics / Q000628:therapy*; D015203:Reproducibility of Results; D054928:Validation Studies as Topic